Methylphenidate hydrochloride and Ventolin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methylphenidate hydrochloride (methylphenidate hydrochloride) and Ventolin (albuterol). Common drug interactions include insomnia among females and anaphylactic reaction among males.
The phase IV clinical study analyzes what interactions people have when they take Methylphenidate hydrochloride and Ventolin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Methylphenidate hydrochloride?
Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 6,823 Methylphenidate hydrochloride users. Check the latest studies of Methylphenidate hydrochloride.
What is Ventolin?
Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
13 people who take Methylphenidate hydrochloride and Ventolin together, and have interactions are studied.

What are the common drug interactions of Methylphenidate Hydrochloride and Ventolin, by gender? *:
female:
- Insomnia (sleeplessness)
- Acne (skin problems that cause pimples)
- Contusion (a type of hematoma of tissue in which capillaries)
- Erythema (redness of the skin)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Pruritus (severe itching of the skin)
- Rash
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Weight decreased
male:
- Anaphylactic reaction (serious allergic reaction)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Genital infection male
- Influenza
- Insomnia (sleeplessness)
- Lacrimation increased
- Malaise (a feeling of general discomfort or uneasiness)
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Pyrexia (fever)
- Rash
What are the common drug interactions of Methylphenidate Hydrochloride and Ventolin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Anaphylactic reaction (serious allergic reaction)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Cough
- Dyspnoea (difficult or laboured respiration)
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
- Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
- Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
- Sputum discoloured
- Erythema (redness of the skin)
- Eye injury
20-29:
- Weight decreased
- Asthenia (weakness)
- Headache (pain in head)
- Insomnia (sleeplessness)
- Lymphangitis (inflammation of the lymph channel)
- Meningitis viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
- Migraine (headache)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Oropharyngeal pain
30-39:
n/a
40-49:
n/a
50-59:
- Disease progression
60+:
- Therapeutic response unexpected
What are the existing conditions these people have? *
- Thyroid Diseases: 4 people, 30.77%
- Impulse-Control Disorder: 4 people, 30.77%
- Hypersensitivity: 4 people, 30.77%
- Disturbance In Attention: 4 people, 30.77%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 15.38%
- Drowsiness: 2 people, 15.38%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 15.38%
- Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 1 person, 7.69%
- Pain: 1 person, 7.69%
- Constipation: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Methylphenidate hydrochloride and Ventolin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methylphenidate hydrochloride (6,823 reports)
- Ventolin (51,849 reports)
Browse all drug interactions of Methylphenidate hydrochloride and Ventolin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methylphenidate hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ventolin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methylphenidate hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ventolin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride and albuterol (the active ingredients of Methylphenidate hydrochloride and Ventolin, respectively), and Methylphenidate hydrochloride and Ventolin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Multivitamin cause Infusion Site Mass? - 3 seconds ago
- Light Chain Analysis Increased and Tooth Abscess - 10 seconds ago
- Could Methotrexate cause Cholesteatoma? - 11 seconds ago
- Drug interactions of Nourianz and Januvia - 14 seconds ago
- Could Multivitamin cause Drug Effect Increased? - 20 seconds ago
- Could Dovonex cause Diabetes? - 29 seconds ago
- Could Hydroxyzine cause Pancytopenia? - 45 seconds ago
- Could Omeprazole cause Perinephric Collection? - 45 seconds ago
- Abdominal Discomfort and Dizziness - 51 seconds ago
- Could Omeprazole cause Adnexa Uteri Pain? - 52 seconds ago